|
|
|
Volumn 23, Issue 147, 2014, Pages 61-64
|
|
Dapagliflozin (New Drug) a hypoglycaemic drug causing disproportionate harm, especially to kidneys
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOTENSIN RECEPTOR ANTAGONIST;
ANTIDIABETIC AGENT;
ANTIHYPERTENSIVE AGENT;
CREATININE;
CYTOCHROME P450 ISOENZYME;
DAPAGLIFLOZIN;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
GLIBENCLAMIDE;
GLIPIZIDE;
GLUCURONOSYLTRANSFERASE 1A9;
HEMOGLOBIN A1C;
INSULIN;
MEFENAMIC ACID;
METFORMIN;
NIFLUMIC ACID;
NONSTEROID ANTIINFLAMMATORY AGENT;
PLACEBO;
RIFAMPICIN;
SARTAN DERIVATIVE;
SULFONYLUREA;
ADD ON THERAPY;
BLADDER CANCER;
BREAST CANCER;
CREATININE BLOOD LEVEL;
DEHYDRATION;
DRUG FATALITY;
DRUG MECHANISM;
DRUG METABOLISM;
FRACTURE;
GLYCEMIC CONTROL;
HEMATOCRIT;
HEPATITIS;
HUMAN;
HYPOTENSION;
KIDNEY;
KIDNEY DYSFUNCTION;
KIDNEY FAILURE;
LIVER DISEASE;
MORBIDITY;
MORTALITY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NONHUMAN;
PREGNANCY;
PRESCRIPTION;
PROSTATE CANCER;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
SHORT SURVEY;
SIDE EFFECT;
TREATMENT CONTRAINDICATION;
UROGENITAL TRACT INFECTION;
WEIGHT REDUCTION;
|
|
EID: 84898742080
PISSN: 11677422
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
|
Times cited : (3)
|
|
References (11)
|
